Skip to content

Ginkgo Bioworks DNA Price / book

Price / book at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Charles River Laboratories logo
Charles River LaboratoriesCRL
2.9×+0.5×
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
1.1×+0.5×
TEC
Bio-TechneTECH
3.9×-0.7×
Azenta logo
AzentaAZTA
0.6×-0.3×
Regenxbio logo
RegenxbioRGNX
20.5×+19.2×

Other financials

Income statement

See full
Revenue$19.5M-49.1%
Gross profit$16.4M-52.0%
Operating income-$71.4M+11.9%
Net income-$82.6M+9.2%
EPS (diluted)-$1.42+27.6%

Balance sheet

See full
Cash & equivalents$188.7M-46.9%
Total debt$410.7M-5.5%
Total equity$443.2M-31.6%
Total assets$1.0B-20.1%

Cash flow

See full
Operating cash flow-$46.7M+9.4%
CapEx$1.9M-74.6%
Free cash flow-$48.6M+17.8%

Valuation

See full
Market cap$625.16M+24.6%
Enterprise value$847.19M+45.9%
P/S4.4×+2.2×

Profitability

See full
Operating margin-210.7%+7.6pp
Net margin-215.4%+8.3pp
FCF margin-119%-21.2pp

Returns & leverage

See full
Return on equity-55.8%-1.8pp
Debt / equity0.9×+0.3×
Current ratio5.2×+0.3×

Where this comes from

Calculated from Ginkgo Bioworks’s reported figures.

Based on the most recent quarter.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ginkgo Bioworks's price / book?
Ginkgo Bioworks (DNA) reported price / book of 0.9× in Q1 2026.
How has Ginkgo Bioworks's price / book changed year-over-year?
Ginkgo Bioworks's price / book increased by 67.7% year-over-year, from 0.5× to 0.9×.
What is the long-term trend for Ginkgo Bioworks's price / book?
Over 4 years (2021 to 2025), Ginkgo Bioworks's price / book has grown at a -42.8% compound annual growth rate (CAGR), from 9.2× to 1×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.